"Leprosy, Lepromatous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic communicable infection which is a principal or polar form of LEPROSY. This disorder is caused by MYCOBACTERIUM LEPRAE and produces diffuse granulomatous skin lesions in the form of nodules, macules, or papules. The peripheral nerves are involved symmetrically and neural sequelae occur in the advanced stage.
| Descriptor ID |
D015440
|
| MeSH Number(s) |
C01.252.410.040.552.386.775.500
|
| Concept/Terms |
Leprosy, Lepromatous- Leprosy, Lepromatous
- Lepromatous Leprosies
- Lepromatous Leprosy
- Leprosies, Lepromatous
Leprosy, Cutaneous- Leprosy, Cutaneous
- Cutaneous Leprosies
- Cutaneous Leprosy
- Leprosies, Cutaneous
- Leprosy, Nodular
- Leprosies, Nodular
- Nodular Leprosies
- Nodular Leprosy
|
Below are MeSH descriptors whose meaning is more general than "Leprosy, Lepromatous".
Below are MeSH descriptors whose meaning is more specific than "Leprosy, Lepromatous".
This graph shows the total number of publications written about "Leprosy, Lepromatous" by people in this website by year, and whether "Leprosy, Lepromatous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 2 | 0 | 2 |
| 2018 | 4 | 0 | 4 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Leprosy, Lepromatous" by people in Profiles.
-
Severe type 2 leprosy reaction with COVID-19 with a favourable outcome despite continued use of corticosteroids and methotrexate and a hypothesis on the possible immunological consequences. Int J Infect Dis. 2021 Feb; 103:549-551.
-
Clinical characteristics and outcomes in patients with COVID-19 and leprosy. J Eur Acad Dermatol Venereol. 2021 Jan; 35(1):e1-e2.
-
Oro-facial manifestations in lepromatous leprosy patients in Central India: clinical findings from a cross-sectional study. Clin Oral Investig. 2020 Jun; 24(6):1981-1986.
-
Recurrent deep venous thrombosis in a leprosy patient on Sofosbuvir regimen for HCV: a lepra reaction? Int J Dermatol. 2018 10; 57(10):e98-e100.
-
Erythema Nodosum Leprosum as a Rare and Challenging Cause of Pyrexia of Unknown Origin. J Assoc Physicians India. 2018 04; 66(4):63-6.
-
Blood coagulation abnormalities in multibacillary leprosy patients. PLoS Negl Trop Dis. 2018 03; 12(3):e0006214.
-
Chronic Nodular Dermatosis: A Quiz. Acta Derm Venereol. 2018 Feb 07; 98(2):299-300.
-
Mycobacterium lepromatosis Lepromatous Leprosy in US Citizen Who Traveled to Disease-Endemic Areas. Emerg Infect Dis. 2017 11; 23(11):1864-1866.
-
Eyebrow and Eyelash Loss. JAMA. 2017 Jan 03; 317(1):81-82.